Dexmedetomidine for sedation during bronchoscopy.
Phase 3
- Conditions
- Health Condition 1: C348- Malignant neoplasm of overlappingsites of bronchus and lungHealth Condition 2: J98- Other respiratory disorders
- Registration Number
- CTRI/2022/07/044389
- Lead Sponsor
- Pt BDS university of health sciences Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Able to and willing to provide informed consent
Exclusion Criteria
1) Clinically important coronary atherosclerotic heart disease, history of stroke or transient ischemic attack
2) Known case of psychiatric illness.
3) Immediate life-threatening comorbidities
4) Requiring NIV during bronchoscopy for other indications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method